A Phase I Study to Determine and Compare Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Intravenous ETX2514 and Sulbactam Administered to Healthy Adult Subjects
Latest Information Update: 27 Aug 2018
At a glance
- Drugs Durlobactam (Primary) ; Sulbactam
- Indications Acinetobacter infections; Gram-negative infections
- Focus Pharmacokinetics
- Sponsors Entasis Therapeutics
- 20 Aug 2018 Results published in the Antimicrobial Agents and Chemotherapy
- 11 Jun 2018 Results presented at the ASM Microbe 2018
- 07 Nov 2017 Status changed from recruiting to completed.